February 14, 20220Comments

Podcast: Why Ignoring Footnotes Could Land Your Portfolio in The Danger Zone

CEO David Trainer sat down with Chuck Jaffe of Money Life to talk about our Danger Zone pick this week: The Real Earnings Season Starts Now: Time to Read Filings & Footnotes.

by Kyle Guske II, Senior Investment Analyst, MBA

February 11, 20220Comments

Affirm’s Results Affirm Our Thesis: Sell This Stock

We are not surprised to see the company guide expectations lower for revenue and profits and the stock has much farther to fall.

by Kyle Guske II, Senior Investment Analyst, MBA

February 9, 20220Comments

Fade the Rumors on Peloton Before the Market Sells the News

Acquiring Peloton (PTON) anywhere close to its current valuation would be a poor use of capital.

by Kyle Guske II, Senior Investment Analyst, MBA

February 7, 20220Comments

Another Falling Knife That Could Cut Your Portfolio – Part 5

This stock has dropped 40%+ from all-time highs, yet still carries at least 40% additional downside risk. Part 5.

by Kyle Guske II, Senior Investment Analyst, MBA

February 7, 20220Comments

Another Falling Knife That Could Cut Your Portfolio – Part 4

This stock has dropped 40%+ from all-time highs, yet still carries at least 40% additional downside risk. Part 4.

by Kyle Guske II, Senior Investment Analyst, MBA

February 7, 20220Comments

Another Falling Knife That Could Cut Your Portfolio – Part 3

This stock has dropped 40%+ from all-time highs, yet still carries at least 40% additional downside risk. Part 3.

by Kyle Guske II, Senior Investment Analyst, MBA

February 7, 20220Comments

Another Falling Knife That Could Cut Your Portfolio – Part 2

This stock has dropped 40%+ from all-time highs, yet still carries at least 40% additional downside risk. Part 2.

by Kyle Guske II, Senior Investment Analyst, MBA

February 7, 20220Comments

Another Falling Knife That Could Cut Your Portfolio – Part 1

This stock has dropped 40%+ from all-time highs, yet still carries at least 40% additional downside risk. Part 1.

by Kyle Guske II, Senior Investment Analyst, MBA

February 7, 20220Comments

Podcast: Why This Pet Food Producer Is in The Danger Zone

CEO David Trainer sat down with Chuck Jaffe of Money Life to talk about our Danger Zone pick this week: Put This Stock in the Doghou

by Kyle Guske II, Senior Investment Analyst, MBA

February 2, 20220Comments

Put This Stock in the Doghouse

This report serves as a reminder of the critical importance of reliable fundamental research in performing the diligence required to fulfill fiduciary responsibilities and protect portfolios from dangerous stocks.

by Matt Shuler, Investment Analyst II

February 2, 20220Comments

Robinhood: Still Nothing But a Gamble

Robinhood’s 4Q21 earnings report underscores our thesis that the stock is wildly overvalued and could fall to as low as $6/share.

by Kyle Guske II, Senior Investment Analyst, MBA

January 31, 20220Comments

Falling Knife You Don’t Want to Catch – Part 5

These Danger Zone stocks have dropped at least 40% from all-time highs, yet still carry at least 40%+ additional downside risk. Part 6.

by Kyle Guske II, Senior Investment Analyst, MBA

January 31, 20220Comments

Falling Knife You Don’t Want to Catch – Part 4

These Danger Zone stocks have dropped at least 40% from all-time highs, yet still carry at least 40%+ additional downside risk. Part 4.

by Kyle Guske II, Senior Investment Analyst, MBA

January 31, 20220Comments

Falling Knife You Don’t Want to Catch – Part 3

These Danger Zone stocks have dropped at least 40% from all-time highs, yet still carry at least 40%+ additional downside risk. Part 3.

by Kyle Guske II, Senior Investment Analyst, MBA

January 31, 20220Comments

Falling Knife You Don’t Want to Catch – Part 2

These Danger Zone stocks have dropped at least 40% from all-time highs, yet still carry at least 40%+ additional downside risk. Part 2.

by Kyle Guske II, Senior Investment Analyst, MBA

January 31, 20220Comments

Falling Knife You Don’t Want to Catch – Part 1

These Danger Zone stocks have dropped at least 40% from all-time highs, yet still carry at least 40%+ additional downside risk. Part 1.

by Kyle Guske II, Senior Investment Analyst, MBA

January 31, 20220Comments

Podcast: Why These Falling Stocks Remain In The Danger Zone

CEO David Trainer sat down with Chuck Jaffe of Money Life to talk about our Danger Zone picks this week: 5 Falling Knives You Don't Want to Catch

by Kyle Guske II, Senior Investment Analyst, MBA

January 27, 20221Comments

Nothing New To See Here

Tesla’s (TSLA) 4Q21 earnings report only underscores our thesis that the stock is wildly overvalued and will fall as low $136/share.

by Kyle Guske II, Senior Investment Analyst, MBA

January 25, 20220Comments

Netflix Is Still Overvalued by At Least $114 Billion

Even after falling 47% from its 52-week high, we think the stock could have a further 66% downside.

by Kyle Guske II, Senior Investment Analyst, MBA

January 24, 20220Comments

Podcast: Three Focus List: Short Stocks Remain In The Danger Zone

CEO David Trainer sat down with Chuck Jaffe of Money Life to talk about our Danger Zone picks this week.

by Kyle Guske II, Senior Investment Analyst, MBA

« Older Articles Newer Articles »